Gene Siegal

Gene Siegal

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
RCRong Chen
Rong Chen
MQMorad Qarmali
Morad Qarmali
GSGene Siegal
Gene Siegal
SWShi Wei
Shi Wei

14 September 2004 in The Journal of Gene Medicine
Verified
Journal Article
Open access
PDF file
DRDaniel T. Rein
Daniel T. Rein
MBMartina Breidenbach
Martina Breidenbach
DNDirk M. Nettelbeck
Dirk M. Nettelbeck
YKYosuke Kawakami
Yosuke Kawakami
GSGene Siegal
Gene Siegal
DCDavid Curiel
David Curiel
Background: Gene therapy is a novel approach for treatment of patients with advanced, recurrent, or metastatic cervical cancer. One effective way to direct transgene expression to specific tissues or tumors is the use of tissue‐specific‐promoters (TSPs). In the context of adenovirus (Ad)‐mediated cancer gene therapy it is rational to choose a TSP which is highly expressed in the tumor but has potentially low activity in non‐tumor cells, especially the liver. In this study, we have investigated several promoters which fulfill these criteria. Candidate cervical cancer specific TSPs include promoters of the genes for secretory leukoprotease inhibitor (SLPI), cyclooxygenase‐2 (COX‐2), Midkine (MK), vascular endothelial growth factor receptor type 1 (flt‐1), vascular endothelial growth factor (VEGF), Survivin and the receptor for chemokine SDS‐1 (CXCR4).Methods: To evaluate the specific gene expression of the different promoters in the context of cervical cancer, we constructed a panel of E1‐deleted Ads that express luciferase under the control of the promoters of interest. We investigated various established cervical cancer cell lines, as well as purified primary cancer cells and normal control cells from the cervix uteri.Results: In all cell lines tested, promoters for MK, VEGF and CXCR4 showed the highest activity. Both MK and VEGF promoters also resulted in a high activity in primary cervical cancer cells. Interestingly, gene expression profiles correlate with luciferase activity in both cell lines and primary cancer samples.Conclusions: Our study demonstrates that the promoters for MK and VEGF are active in cervical cancer. We believe that both promoters can be successfully employed as TSPs for gene therapy targeted to cervical cancer. Copyright © 2004 John Wiley & Sons, Ltd.

1 May 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
MSMark E Sobel
Mark E Sobel
JDJennifer C. Dreyfus
Jennifer C. Dreyfus
KMKelsey Dillehay McKillip
Kelsey Dillehay McKillip
CKChristi Kolarcik
Christi Kolarcik
WMWilliam A. Muller
William A. Muller
TOTIMOTHY OLEARY
TIMOTHY OLEARY

10 August 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
RARana Aldrees
Rana Aldrees
XGXiaoqing Gao
Xiaoqing Gao
KZKui Zhang
Kui Zhang
GSGene Siegal
Gene Siegal
SWShi Wei
Shi Wei

4 May 2021 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
PDF file
RMRaima A. Memon
Raima A. Memon
SWShi Wei
Shi Wei
GSGene Siegal
Gene Siegal
Context.—: A number of fibro-osseous and osteocartilaginous lesions, especially common in the small bones of the hand and feet, pose a diagnostic challenge and have historically been thought to be reactive lesions. However, modern molecular techniques when supplementing clinical, radiographic, and histologic evaluation suggest they may, in fact, be neoplasms. Objective.—: To review the clinical presentation and histopathologic, molecular, and radiologic features of selective bone lesions, focusing most specifically on subungual exostosis, florid reactive periostitis, and bizarre periosteal osteochondromatous proliferation. Data Sources.—: Literature review and personal experience are the sources of this review. Conclusions.—: Some lesions previously thought to be reactive are locally aggressive and demonstrate reproducible molecular abnormalities, and thus may be neoplasms. Although most common in the bones of the fingers and toes, these lesions also occur in long and other bones. The clinical presentations, radiologic appearances, and histopathologic features often overlap, making the diagnosis challenging, and these lesions may require molecular evaluation to maximize accurate prognostication.

1 December 2021 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
FFFei Fei
Fei Fei
KZKui Zhang
Kui Zhang
GSGene Siegal
Gene Siegal
SWShi Wei
Shi Wei